129 related articles for article (PubMed ID: 21585380)
1. Effect of bile on the oral absorption of halofantrine in polyethylene glycol 400 and polysorbate 80 formulations dosed to bile duct cannulated rats.
Tønsberg H; Holm R; Mu H; Boll JB; Jacobsen J; Müllertz A
J Pharm Pharmacol; 2011 Jun; 63(6):817-24. PubMed ID: 21585380
[TBL] [Abstract][Full Text] [Related]
2. Effects of polysorbate 80 on the in-vitro precipitation and oral bioavailability of halofantrine from polyethylene glycol 400 formulations in rats.
Tønsberg H; Holm R; Bisgaard J; Jacobsen J; Müllertz A
J Pharm Pharmacol; 2010 Jan; 62(1):63-70. PubMed ID: 20723000
[TBL] [Abstract][Full Text] [Related]
3. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
Lind ML; Jacobsen J; Holm R; Müllertz A
Eur J Pharm Sci; 2008 Oct; 35(3):211-8. PubMed ID: 18675904
[TBL] [Abstract][Full Text] [Related]
4. Using resin to generate a non-invasive intestinal bile-depleted rat model was unsuccessful.
Holm R; Hesselkilde JZ; Jørgensen EB; Müllertz A
Eur J Pharm Sci; 2012 Sep; 47(2):347-51. PubMed ID: 22732256
[TBL] [Abstract][Full Text] [Related]
5. Influence of bile on the absorption of halofantrine from lipid-based formulations.
Holm R; Tønsberg H; Jørgensen EB; Abedinpour P; Farsad S; Müllertz A
Eur J Pharm Biopharm; 2012 Jun; 81(2):281-7. PubMed ID: 22465095
[TBL] [Abstract][Full Text] [Related]
6. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system.
Dannenfelser RM; He H; Joshi Y; Bateman S; Serajuddin AT
J Pharm Sci; 2004 May; 93(5):1165-75. PubMed ID: 15067693
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture.
Joshi HN; Tejwani RW; Davidovich M; Sahasrabudhe VP; Jemal M; Bathala MS; Varia SA; Serajuddin AT
Int J Pharm; 2004 Jan; 269(1):251-8. PubMed ID: 14698596
[TBL] [Abstract][Full Text] [Related]
8. Decrease in gastrointestinal absorption of roxithromycin in bile duct cannulated rats due to depletion of bile salts.
Lee JH; Park YJ; Oh JH; Lee YJ
Biopharm Drug Dispos; 2013 Sep; 34(6):360-4. PubMed ID: 23703541
[TBL] [Abstract][Full Text] [Related]
9. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
Feeney OM; Williams HD; Pouton CW; Porter CJ
J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
[TBL] [Abstract][Full Text] [Related]
10. The influence of bile acids on the oral bioavailability of vitamin K encapsulated in polymeric micelles.
van Hasselt PM; Janssens GE; Slot TK; van der Ham M; Minderhoud TC; Talelli M; Akkermans LM; Rijcken CJ; van Nostrum CF
J Control Release; 2009 Jan; 133(2):161-8. PubMed ID: 18955093
[TBL] [Abstract][Full Text] [Related]
11. Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats.
Holm R; Porter CJ; Müllertz A; Kristensen HG; Charman WN
Pharm Res; 2002 Sep; 19(9):1354-61. PubMed ID: 12403073
[TBL] [Abstract][Full Text] [Related]
12. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
Yeap YY; Trevaskis NL; Quach T; Tso P; Charman WN; Porter CJ
Mol Pharm; 2013 May; 10(5):1874-89. PubMed ID: 23480483
[TBL] [Abstract][Full Text] [Related]
13. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
14. Solution or suspension - Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug.
Larsen AT; Holm R; Müllertz A
Eur J Pharm Biopharm; 2017 Aug; 117():308-314. PubMed ID: 28465239
[TBL] [Abstract][Full Text] [Related]
15. Study of the physicochemical properties and oral bioavailability of the solid dispersion of cantharidin with polyethylene glycol 4000.
Dang YJ; Hu CH; An LN; Zhu CY
Methods Find Exp Clin Pharmacol; 2010 Apr; 32(3):157-62. PubMed ID: 20448857
[TBL] [Abstract][Full Text] [Related]
16. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
Wu H; Zhou A; Lu C; Wang L
Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
[TBL] [Abstract][Full Text] [Related]
17. The lymph lipid precursor pool is a key determinant of intestinal lymphatic drug transport.
Trevaskis NL; Porter CJ; Charman WN
J Pharmacol Exp Ther; 2006 Feb; 316(2):881-91. PubMed ID: 16249368
[TBL] [Abstract][Full Text] [Related]
18. Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats.
Karpf DM; Holm R; Kristensen HG; Müllertz A
Pharm Res; 2004 Aug; 21(8):1413-8. PubMed ID: 15359576
[TBL] [Abstract][Full Text] [Related]
19. Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats.
Holm R; Müllertz A; Christensen E; Høy CE; Kristensen HG
Eur J Pharm Sci; 2001 Dec; 14(4):331-7. PubMed ID: 11684408
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
